SEC Filings

SEC Filings

Filing date Description Form Filing Group Issuer View
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Eidos Therapeutics, Inc.
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Eidos Therapeutics, Inc.
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Eidos Therapeutics, Inc.
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
Eidos Therapeutics, Inc.
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Eidos Therapeutics, Inc.
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Eidos Therapeutics, Inc.
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
Eidos Therapeutics, Inc.
View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
Eidos Therapeutics, Inc.

Copyright Morningstar